Mallinckrodt Plc - Company Profile
Powered by 
All the data and insights you need on Mallinckrodt Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Mallinckrodt Plc Strategy Report
- Understand Mallinckrodt Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Mallinckrodt Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Mallinckrodt Plc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Paul M. Bisaro
Chairman Executive BoardMr. Paul M. Bisaro has been Chairman of the company's Board of Directors since June 2022. Previously, he as the President, Chief Executive Officer and a Director on the board of Impax Laboratories from 2016 to 2018, and as Executive Chairman of Amneal Pharmaceuticals from 2019. Prior to Impax, Mr. Bisaro has served as an Executive Chairman of Allergan from 2014 to 2016, and President and Chief Executive Officer of Actavis (and its predecessor firm Watson Pharmaceuticals). Before this, he served as President, Chief Operating Officer and a Director on the Board of Barr Pharmaceuticals. Prior to this, he also served as a Director on the boards of Zoetis.
Sigurdur O. Olafsson
Director; Chief Executive Officer; President Executive BoardMr. Sigurdur Olafsson has been President, Chief Executive Officer and a Director of the company since June 2022. Before this, he served as Chief Executive Officer of Hikma Pharmaceuticals. Prior to Hikma, he served as President and Chief Executive Officer of the Global Generic Medicines Group of Teva Pharmaceuticals. Prior to this, he was President of Actavis plc (Watson) and CEO of the Actavis Group. He also served leadership positions in Pfizer’s Global R&D organization in the UK and U.S. He also served as Head of Drug Development for Omega Farma in Iceland.
Bryan M. Reasons
Chief Financial Officer; Executive Vice President Senior ManagementMr. Bryan Reasons has been the Chief Financial Officer and the Executive Vice President of the company since 2019. Prior to this, he served as the Chief Financial Officer and Senior Vice President at Impax Laboratories. Previously, Mr. Bryan served in various roles at Cephalon Inc and E. I. Du Pont De. He also served as Audit Committee Chair and Independent Board of Director at Aclaris Therapeutics Inc and Recro Pharma Inc.
Mark Tyndall
Executive Vice President; Chief Legal Officer; Corporate Secretary Senior ManagementMr. Mark Tyndall has been the Corporate Secretary and Executive Vice President and Chief Legal Officer of the company since 2022. Prior to this he served as a Senior Vice President and U.S. General Counsel at Mallinckrodt.
Kassie Harrold
Executive Vice President; Chief Compliance Officer Senior ManagementKassie Harrold has been the Executive Vice President and Chief Compliance Officer of the company. Prior to this, he held several positions, including global compliance, litigation and employment counsel and government affairs, with Solutia Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer